MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 05-13-2026
Brainsway Ltd. Total Liabilities 2011-2026 | BWAY
Annual Total Liabilities Brainsway Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14.4 M | 14.5 M | 16.6 M | 14.3 M | 9.68 M | 9.35 M | 10.2 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.6 M | 9.35 M | 12.7 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 1.32 | -19.02 % | $ 1.76 M |  USA |
 |
Agilent Technologies
A
|
5.32 B | $ 112.31 | -0.84 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
108 M | $ 19.54 | 3.5 % | $ 566 M | USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 140.5 | -1.91 % | $ 22.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
110 M | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 94.39 | -2.36 % | $ 6.37 B | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 419.67 | 0.12 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 053.18 | 1.08 % | $ 21.7 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
523 M | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
121 M | $ 18.68 | -1.29 % | $ 418 M | USA |
 |
Natera
NTRA
|
689 M | $ 187.81 | -4.62 % | $ 18.5 B | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 155.3 | -2.4 % | $ 7.7 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 25.3 | -0.82 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
2.11 B | $ 93.62 | -5.11 % | $ 11.7 B | USA |
 |
Personalis
PSNL
|
73 M | $ 6.53 | -2.68 % | $ 583 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 5.74 | -1.37 % | $ 240 M | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 117.02 | -0.06 % | $ 9.65 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
114 M | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
1.84 M | $ 2.33 | -3.32 % | $ 5.35 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 251.91 | -0.83 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 441.56 | -1.47 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.56 | -3.84 % | $ 201 M | Irlanda |
 |
Celcuity
CELC
|
366 M | $ 135.89 | 0.86 % | $ 6.35 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 49.5 | -6.52 % | $ 2.96 B | USA |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 8.28 | -1.84 % | $ 1.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 187.84 | -0.05 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | USA |